Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Genkyotex Innovation SAS
ClinicalTrials.gov Identifier:
NCT02010242
First received: June 18, 2013
Last updated: October 20, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2015
  Estimated Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)